Cargando…
CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer
PURPOSE: Metastasis and local recurrence are the primary causes of treatment failure and patient death in breast cancer. The aim of this study was to validate a metastasis- and local recurrenceassociated biomarker for prognostic evaluation and planning treatment strategies. METHODS: Formalin-fixed,...
Autores principales: | Ye, Feng, Zhong, Xiaorong, Qiu, Yan, Yang, Libo, Wei, Bing, Zhang, Zhang, Bu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500397/ https://www.ncbi.nlm.nih.gov/pubmed/28690650 http://dx.doi.org/10.4048/jbc.2017.20.2.142 |
Ejemplares similares
-
The Presence of EpCAM(-)/CD49f(+) Cells in Breast Cancer Is Associated with a Poor Clinical Outcome
por: Ye, Feng, et al.
Publicado: (2015) -
Genomic alterations of oligodendrogliomas at distant recurrence
por: Liu, Guanzheng, et al.
Publicado: (2023) -
Late Local and Distant Recurrence of Apparently Benign Paraganglioma
por: Singh, Brijesh K, et al.
Publicado: (2022) -
Genomic Views of Distant-Acting Enhancers
por: Visel, Axel, et al.
Publicado: (2009) -
Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology
por: Khademi, Rahele, et al.
Publicado: (2023)